|
|
|
|
|
|
|
07.04.25 - 14:48
|
Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies (GlobeNewswire EN)
|
|
VANCOUVER, British Columbia, April 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it will be attending the Tennessee Safety and Health Conference (TSHC) in Nashville, TN commencing on April 7th. Cannabix will attend the conference with AlcoPro Inc. to exhibit the Company's laboratory-based Marijuana Breath Test (MBT) and BreathLogix autonomous (unmanned) alcohol screening device (See Figures 1-3). The TSHC supported by the Tennessee Occupational Safety and Health Administration (TOSHA) and offers a variety of workplace safety and health education sessions geared toward managers as well as front-line workers and will be attended by corporations and professionals in the drug and alcohol testing industry....
|
|
01.04.25 - 14:33
|
Cannabix Technologies to Attend U.S. National Drug and Alcohol Conference to Market Marijuana Breath Test (GlobeNewswire EN)
|
|
VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that it will be attending the National Drug and Alcohol Screening Association (NDASA) conference in Florida in early April alongside strategic partner, Omega Laboratories, to begin joint marketing of the Company's Marijuana Breath Test (MBT). NDASA is one of the world's largest organizations providing education and resources for workplace safety. The conference will be attended by corporations and professionals in the drug and alcohol testing industry from around the world. This comes on the heels of a laboratory validation milestone with the Cannabix Marijuana Breath Test by strategic partner Omega Laboratories (“Omega”)....
|
|
|
|
14.03.25 - 23:18
|
Cannabix Technologies announces Stock Option Grant and Director Resignation (GlobeNewswire EN)
|
|
VANCOUVER, British Columbia, March 14, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports it is granting 3,375,000 incentive stock options to officers, directors and consultants of the Company, exercisable at $0.54 per share for five years, of which 650,000 will expire in two years and will be subject to vesting provisions....
|
|
24.01.25 - 14:48
|
Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing (GlobeNewswire EN)
|
|
VANCOUVER, British Columbia, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that it has entered a memorandum of understanding (“MOU”) with AlcoPro Inc. (“AlcoPro”) of Knoxville, TN, to begin collaborating on marketing efforts for the Cannabix Marijuana Breathalyzer (“CMB”) technology in the United States. In the short-term, AlcoPro will include the CMB hardware in its upcoming 2025 product catalogue, mailed to over 70,000 businesses in U.S. and globally. AlcoPro is a well-established distributor and leading supplier of drug and alcohol testing instruments, kits, and supplies for professional use, since 1982....
|
|
09.01.25 - 14:48
|
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology (GlobeNewswire EN)
|
|
VANCOUVER, British Columbia, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that it has made significant updates to its Cannabix Marijuana Breathalyzer (“CMB”) technology to meet suggested emerging regulatory requirements in preparation for marketing. Cannabix engineers have incorporated several new features to the Company's Breath Collection Unit (“BCU”) – a critical hardware tool used for portable collection of delta-9 THC in breath (images below). These developments come as the need for marijuana breath detection gains intensity in the United States and globally....
|
|
|
|
|
11.07.24 - 14:18
|
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing (GlobeNewswire EN)
|
|
VANCOUVER, British Columbia, July 11, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) reports that early testing by Omega Laboratories Inc (“Omega Laboratories” or “Omega”) with the Company's marijuana breathalyzer technology have garnered positive results. Omega has commenced pre-validation scoping work to establish limits of detection (LOD) and limits of quantification (LOQ) as well as the cutoff level for the detection of delta-9 THC (primary psychoactive ingredient in cannabis) in breath. Recently, Cannabix entered into a strategic partnership and development agreement with Omega Laboratories to advance the development and commercialization of the Cannabix marijuana breathalyzer technology. Omega Laboratories is an international industry leader in forensic drugs of abuse testing with multiple international certifications and accreditations....
|
|
19.06.24 - 01:03
|
Cannabix Technologies Annual General and Special Meeting Results (GlobeNewswire EN)
|
|
VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) announces the results of its annual general and special meeting of common shareholders held on June 18, 2024 in Vancouver. Resolutions passed at the meeting included the appointment of Saturna Group Chartered Accountants LLP as auditors for the ensuing year, an ordinary resolution to approve the adoption of the Company's Stock Option Incentive Plan and the granting of stock options thereunder in an amount up to 15% of the total issued and outstanding shares, an ordinary resolution to approve the adoption of the Company's Restricted Share Unit Incentive Plan and the granting of equity awards thereunder in an amount up to 5% of the total issued and outstanding shares, and the election of Dr. Raj Attariwala, Dr. Phillip Olla, Rav Mlait, Bryan Loree, and Thomas Clarke as directors....
|
|